Chanice Henry | 02/16/2016
The Active Pharmaceutical Ingredient (API) market is segmented into Innovative APIs and generic APIs, with the former representing the majority of the market. The main cause of this being attributed to the patent protection measures and the higher price point for innovative APIs.According to statistics from the “Active Pharmaceutical Ingredient Market - Global Forecast to 2020" the global active pharmaceutical ingredient market is expected to climb to US$205.51 billion by 2020. The G...
To continue reading this story Click Here
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Sustainability and Inclusivity in Pharma Manufacturing: Insights from AstraZeneca’s People Hub
2024-12-11
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More